Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 13, 2016 2:59 AM ET

Capital Markets

Company Overview of Concord International Investments Group, LP

Company Overview

Concord International Investments Group, LP is a privately owned investment manager. The firm also provides real estate investment advisory services to its clients. It primarily provides its services to individuals, typically high net worth individuals, investment companies, families, foundations, institutions, and banking or thrift institutions. The firm manages client specific, customized portfolios for its clients. It also manages mutual funds. The firm invests in the fixed income markets of the United States. It conducts in-house research to make its investments. The firm also seeks to make private equity and real estate investments. It prefers to invest in industrial, commercial, and to...

610 Fifth Avenue

6th Floor

New York, NY 10020

United States

Founded in 1988





Key Executives for Concord International Investments Group, LP

Chairman and Founder
Age: 76
Chief Operating Officer
Senior Managing Director, Chairman of the Executive Committee, and Chairman of Investment Committee
Age: 73
Senior Managing Director, Head of Research, and Member of the Executive Committee
Senior Managing Director and Senior Portfolio Manager
Compensation as of Fiscal Year 2015.

Concord International Investments Group, LP Key Developments

Valeant Reportedly In Talks To Buy Amoun

Valeant Pharmaceuticals International Inc. is in talks to acquire Amoun Pharmaceutical Company S.A.E., according to people with knowledge of the matter. Negotiations are at an early stage and may still fall apart, the people said, asking not to be identified because the discussions are private. Shareholder of Amoun Pharmaceuticals include Capital Group, Concord International Investments Group, LP and The Rohatyn Group, LLC. Representatives for Amoun, Rohatyn and Valeant declined to comment, while representatives for Capital Group and Concord International didn’t respond to requests for comment.

Similar Private Companies By Industry

Company Name Region
Merritt Healthcare Solutions United States
Toussaint Capital Partners, LLC United States
Gainey Financial Services, Inc. United States
Gregory Schwartz & Co. United States
Broadwater & Associates LLC United States

Recent Private Companies Transactions

July 17, 2015
Amoun Pharmaceutical Company S.A.E.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Concord International Investments Group, LP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at